Tag Archives: TSRI

October, 2017

  • 26 October

    New Study: ‘Double Decker’ Antibody Technology Fights Cancer

    JUPITER, Fla., Oct. 25, 2017 /PRNewswire-USNewswire/ — Scientists from the Florida campus of The Scripps Research Institute (TSRI) have created a new class of antibody-drug conjugates (ADCs), using a versatile “double decker” technology that ties antibodies and a drug together to produce highly potent pharmaceuticals for cancer therapy. The new …

March, 2017

November, 2016

October, 2016

May, 2016

October, 2015